Drug Detail:Bevespi aerosphere (Formoterol and glycopyrrolate [ for-moe-ter-ol-and-glye-koe-pir-oh-late ])
Generic Name: GLYCOPYRROLATE 9ug, FORMOTEROL FUMARATE 4.8ug
Dosage Form: aerosol, metered
Drug Class: Bronchodilator combinations
Drug Detail:Bevespi aerosphere (Formoterol and glycopyrrolate [ for-moe-ter-ol-and-glye-koe-pir-oh-late ])
Generic Name: GLYCOPYRROLATE 9ug, FORMOTEROL FUMARATE 4.8ug
Dosage Form: aerosol, metered
Drug Class: Bronchodilator combinations
The recommended dosage of BEVESPI AEROSPHERE is glycopyrrolate 18 mcg and formoterol fumarate 9.6 mcg (administered as two inhalations of BEVESPI AEROSPHERE [glycopyrrolate/formoterol fumarate 9 mcg/4.8 mcg]) twice daily in the morning and in the evening by oral inhalation. Do not take more than two inhalations twice daily.
Prime BEVESPI AEROSPHERE before using for the first time. Priming BEVESPI AEROSPHERE is essential to ensure appropriate drug content in each actuation. To prime BEVESPI AEROSPHERE, release 4 sprays into the air away from the face, shaking well before each spray. BEVESPI AEROSPHERE must be re-primed when the inhaler has not been used for more than 7 days. To re-prime BEVESPI AEROSPHERE, release 2 sprays into the air away from the face, shaking well before each spray.
The canister has an attached dose indicator, which indicates how many inhalations remain. The dose indicator display will move after every tenth actuation. When nearing the end of the usable inhalations, the color behind the number in the dose indicator display window changes to red. BEVESPI AEROSPHERE should be discarded when the dose indicator display window shows zero.